Risk factors and fetal outcomes for preeclampsia in a Colombian cohort
Paola Ayala-Ramírez,
Natalia Serrano,
Viviana Barrera,
Juan Pablo Bejarano,
Jaime Luis Silva,
Rodolfo Martínez,
Fabian Gil,
Mercedes Olaya-C,
Reggie García-Robles
Affiliations
Paola Ayala-Ramírez
Human Genetics Institute, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia; Corresponding author.
Natalia Serrano
Research Seedbed in Perinatal Medicine Pontificia Universidad Javeriana: Medical School Pontificia Universidad Javeriana and Medical Residents Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Viviana Barrera
Research Seedbed in Perinatal Medicine Pontificia Universidad Javeriana: Medical School Pontificia Universidad Javeriana and Medical Residents Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Juan Pablo Bejarano
Research Seedbed in Perinatal Medicine Pontificia Universidad Javeriana: Medical School Pontificia Universidad Javeriana and Medical Residents Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Jaime Luis Silva
Department of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Rodolfo Martínez
Department of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Fabian Gil
Clinical Epidemiology and Biostatistics Department, Medical School, Pontificia Universidad Javeriana, Bogota, Colombia
Mercedes Olaya-C
Department of Pathology, Faculty of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Reggie García-Robles
Department of Physiological Sciences, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
In Latin America and the Caribbean, hypertensive pregnancy disorders are responsible for almost 26% of all maternal deaths [1] and, in Colombia, they account for 59% of all severe maternal morbidity (SMM) cases, and 59.7% of all SMM cases in adolescents [2]. One of the most important hypertensive pregnancy disorders is preeclampsia (PE). Lives can be saved, if PE is prevented, or detected early and properly managed. Prevention and detection depend on identifying the risk factors associated with PE, and, as these have been shown vary by population, they should be determined on a population-by-population basis. The following study utilized the nested case-control model to evaluate 45 potential PE risk factors of a cohort in Bogotá, Colombia, making it perhaps the most comprehensive study of its kind in Colombia. It found PE to have a statistically significant association with 7 of the 45 factors evaluated: 1) pre-gestational BMI >30 kg/m2, 2) pregnancy weight gain >12 kg, 3) previous history preeclampsia/eclampsia, 4) previous history of IUGR-SGA (Intrauterine Growth Restriction-Small for Gestational Age), 5) maternal age <20 or ≥35 years (20–34 was not associated), and 6) family history of diabetes. Finally, prenatal consumption of folic acid was found to lower the risk of PE. We recommend that, in Colombia, factors 1–6 be used to identify at risk mothers during pregnancy check-ups; that mothers be encouraged to take folic acid during pregnancy; and, that Colombia's health system and public policy address the problem of pregestational obesity.